Related Experiment Videos
HLA antigens in systemic lupus erythematosus
Annals of the Rheumatic Diseases
|February 1, 1977
Summary
The human leukocyte antigen B8 (HLA-B8) is linked to systemic lupus erythematosus (SLE). Patients with HLA-B8 have a significantly higher risk of developing SLE.
Area of Science:
- Immunogenetics
- Rheumatology
- Autoimmune Diseases
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- Genetic factors play a role in SLE susceptibility.
- Human Leukocyte Antigen (HLA) genes are known immune system regulators.
Purpose of the Study:
- To investigate the association between serologically defined HLA antigens and SLE.
- To determine the prevalence of specific HLA antigens in SLE patients.
- To assess the risk conferred by HLA antigens in SLE development.
Main Methods:
- Serological typing of HLA antigens was performed.
- A cohort of 45 SLE patients was analyzed.
- Comparison was made with a control group.
Main Results:
- The HLA-B8 antigen was present in 37.8% of SLE patients.
- HLA-B8 was found in 22% of the control group.
- Carriage of HLA-B8 increased the risk of developing SLE by 2.15-fold.
Conclusions:
- The HLA-B8 antigen is significantly associated with systemic lupus erythematosus.
- HLA-B8 is a potential genetic marker for SLE susceptibility.
- Further research into HLA-B8's role in SLE pathogenesis is warranted.